Antitumor effects of a novel photosensitizer-mediated photodynamic therapy and its influence on the cell

Jingjing Chen1, Dan Wang2, Zequn Wang2

  • 1Department of Pharmacology, School of Pharmacy, Changzhi Medical College, Changzhi, China.

Oncology Research
|April 30, 2024
PubMed

Insights

This study shows that photodynamic therapy (PDT) using a novel photosensitizer (DTP) effectively inhibits cancer cell growth. DTP-PDT induces cell death via reactive oxygen species (ROS) and apoptosis, involving the P38 MAPK pathway and affecting cell cycle genes.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Photodynamic therapy (PDT) is an emerging cancer treatment modality.
  • Novel photosensitizers are crucial for enhancing PDT efficacy.
  • Understanding the molecular mechanisms of PDT is essential for its clinical application.

Purpose of the Study:

  • To investigate the antitumor effects of a novel photosensitizer, meso-5-[ρ-diethylene triamine pentaacetic acid-aminophenyl]-10,15,20-triphenyl-porphyrin (DTP), mediated photodynamic therapy (DTP-PDT).
  • To elucidate the underlying mechanisms of DTP-PDT, including its impact on cell viability, reactive oxygen species (ROS) generation, apoptosis, autophagy, and gene expression.

Main Methods:

  • Cell viability was assessed using the Cell Counting Kit-8 assay.
  • ROS generation was measured using the DCFH-DA fluorescent probe.
  • Apoptosis was evaluated via Hoechst staining and western blotting for apoptosis-related proteins (Bax, Bcl-2).
  • Autophagy was monitored by assessing LC3B-II levels.
  • RNA sequencing and subsequent bioinformatic analyses (GO, KEGG, Disease Ontology, Reactome, PPI) were performed to identify differentially expressed genes and pathways.

Main Results:

  • DTP-PDT significantly inhibited cell growth and induced ROS generation in MCF-7 and SGC7901 cancer cell lines.
  • DTP-PDT-induced cytotoxicity was attenuated by a ROS scavenger (NAC) and a P38 MAPK inhibitor (SB203580).
  • Apoptosis was induced by DTP-PDT, evidenced by altered Bax/Bcl-2 ratios, and this effect was also sensitive to NAC and SB203580.
  • DTP-PDT increased the level of LC3B-II, indicating induction of autophagy.
  • RNA sequencing identified 3496 differentially expressed mRNAs, enriched in pathways related to cell cycle, ribosomes, DNA replication, and protein binding, with cdk1 and rps27a identified as key interacting genes.

Conclusions:

  • DTP-PDT demonstrates significant antitumor activity by inhibiting cell proliferation and inducing apoptosis and autophagy.
  • The mechanisms involve ROS generation and activation of the P38 MAPK signaling pathway.
  • Key molecular changes induced by DTP-PDT are associated with cell cycle regulation, ribosomal function, DNA replication, and protein binding, offering potential therapeutic targets.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K